Show simple item record

dc.date.accessioned2023-05-09T11:34:56Z
dc.date.available2023-05-09T11:34:56Z
dc.date.issued2020-04-02
dc.identifier.citationNational Centre for Pharmacoeconomics (NCPE Ireland), Medicines Management Programme (MMP), National Medicines Information Centre (NMIC), COVID-19 Evidence Review Group for Medicines, 'Clinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19', [report], 2020-04-02en
dc.language.isoenen
dc.rightsYen
dc.subjectCovid-19en
dc.subjectCoronavirusen
dc.subjectHydroxychloroquineen
dc.subjectAzithromycinen
dc.subjectCombination therapyen
dc.titleClinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19en
dc.typereporten
dc.type.supercollectionedepositireland
dc.contributor.corporatenameNational Centre for Pharmacoeconomics (NCPE Ireland)en
dc.contributor.corporatenameMedicines Management Programme (MMP)en
dc.contributor.corporatenameNational Medicines Information Centre (NMIC)en
dc.contributor.corporatenameCOVID-19 Evidence Review Group for Medicinesen
dc.publisher.placeirelanden
dc.description.versionVersion 2en
dc.rights.ecaccessrightsopenAccess
dc.relation.relatedtoTCD Covid-19 Collection
dc.identifier.urihttp://hdl.handle.net/2262/102606


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record